Poor
Poorly Aligned
Patient Risk:
Low
Summary
The AI-generated claims largely do not align with the FDA-approved labeling. Only a few statements are supported by the label (notably/grapefruit interaction and warfarin interaction), with several claims absent from the label or explicitly contradicted. Several items constitute dangerous misstatements. Overall alignment is poor.
Category Scores
Accurate Statements
Lipitor is an HMG-CoA reductase inhibitor (statin) used to lower LDL-C.
12.1
Grapefruit/grapefruit juice can inhibit CYP3A4 and increase atorvastatin exposure.
7.2
Rare additive effects are possible.
5.1
LIPITOR had no clinically significant effect on prothrombin time when administered to patients receiving chronic warfarin treatment.
7.7
Unsupported Statements
Multivitamins can be taken with Lipitor.
Absent from label
No major interactions occur between atorvastatin and standard multivitamins.
Absent from label
Standard multivitamins typically contain vitamins A, B-complex, C, D, E, and minerals like calcium, magnesium, or zinc at low doses.
Absent from label
Multivitamins don't contain grapefruit.
Absent from label
If your multivitamin includes grapefruit seed extract (rare), skip it.
Absent from label
Multivitamins should contain 20-50 mg niacin.
Absent from label
Vitamin K is present in low amounts in multivitamins.
Absent from label
Vitamin K doesn't counteract Lipitor.
Absent from label
Vitamin K could slightly affect blood thinners if you're also on warfarin.
Contradicted by label
Everyday multis like Centrum or One A Day are fine for most patients.
Absent from label
Take your multivitamin with food to boost absorption.
Absent from label
Separate from Lipitor if possible.
Absent from label
Lipitor at night works best since cholesterol production peaks then.
Absent from label
Morning multi and evening Lipitor avoids any minor absorption overlap with minerals like calcium.
Absent from label
Clinical guidelines from the American Heart Association list no contraindications for multivitamins with statins.
Absent from label
FDA guidelines list no contraindications for multivitamins with statins.
Absent from label
A 2020 review in Pharmacotherapy confirmed no pharmacokinetic clashes with atorvastatin and common supplements.
Absent from label
Doctors or pharmacists can review your specific multi's label via tools like Drugs.com interaction checker.
Absent from label
If you have kidney issues, high-calcium multis might need monitoring with Lipitor.
Absent from label
Prenatal multis are okay but confirm dosing.
Dangerous misstatement; pregnancy is a pharmacologic contraindication for atorvastatin
If you have symptoms like unusual muscle pain or weakness, stop the multivitamin and call your doctor.
Dangerous misstatement; stopping a multivitamin is not the recommended response; label instructs stopping atorvastatin if myopathy is diagnosed or suspected
Contradictions
Low
AI Statement
Vitamin K could slightly affect blood thinners if you're also on warfarin.
Label Reference
7.7
Important Omissions
Pregnancy contraindication for atorvastatin
Importance:
High
Explicit dosing/timing guidance for atorvastatin (e.g., preferred time of day) in label text provided
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
The evaluated claims largely miss label-supported safety guidance; only a few statements align with the label (e.g., grapefruit interaction, warfarin interaction, rare additive effects). Several claims misstate or misinterpret safety information (e.g., prenatal use, stopping a multivitamin for myopathy).
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Poorly Aligned
Primary Issue
Substantial number of claims are not supported by the FDA label; presence of dangerous misstatements; contradiction identified.
Suggested Improvement
Limit assertions to FDA-labeled statements; remove content about multivitamin contents, brand endorsements, and dosing thresholds not present in label; accurately reflect interactions (grapefruit, warfarin) and monitoring recommendations; clearly state contraindications (e.g., pregnancy) as per label.